New strategy to inhibit RANK pathway for the treatment of TNBC. RANK is expressed in 40% of TNBC where it was linked with poor clinical outcomes. Cost-effective therapy for TNBC and NSCLC easing the economic burden

An attempt to restore the immune homeostasis from patients suffering from immune-inflammatory processes such as GvHD, autoimmune diseases and transplant rejection. This physiological immunomodulator overcomes the side effects of the present immunosuppressive and anti-inflammatory drugs, and enables to perform pharmacological therapy.

A new device for endo-luminal linear anastomosis (ELLA) surgeries. A stapler to reduce surgical trauma. A novel safe and easy approach of laparoscopic procedure.

New predictive drug companion biomarker. NCE for Tumors AA-resistant treatment. In Vitro test for diagnosis, prognosis & prediction of response to cancer treatment.

A real-time software to facial paralysis patients rehabilitation. An improvement of the existing mirror therapy.

Non-invasive azoospermia biomarkers & Kit development. High sensitivity and specificity (>90%). Effective azoospermia test in seminal plasma to avoid unnecessary biopsies.

Easy-to-use web-based platform to identify biomarkers. Specific neuropsychiatric symptoms-guided brain disorder identification. First diagnosis for effective treatment selection.

This nanotechnology reduces the radiation dose for an effective treatment. Increasing the array of tumors capable to treat by standard. Brachytherapy.

Prognostic biomarker for cutaneous and uveal melanoma. Combination therapy for metastatic melanoma. Inhibition of metastasis and survival of cancer Stem Cells.

Biosensor-based Video Game. Mobile/tablet device app development. Improvement of impulsivity in patients with gambling and eating disorders.

Novel urine biomarker for cystine lithiasis. Natural compound with no described toxicity to retard cystine lithiasis onset.

A flexible, scaled and integrated e-Health educational and psychosocial services program that guarantees correct screening, monitoring and support in health education, adherence to treatments, and the provision of emotional care and psychosocial cancer quality.

New approach to avoid complications in reconstructive and aesthetic breast surgery. Coated breast prosthesis to avoid infections.

Vulnerable atherothrombotic plaque identification using blood circulating miRNA biomarkers. Point-of-Care microfluidics paperbased analytical device (μPADs) integration (in co-development with Paperdrop Diagnostics S.L.).